BioStem Technologies, Inc. began construction of its new pharmaceutical grade lab facility. The new facility will house multiple general labs, clean rooms, and small batch manufacturing rooms to support production and development of pharmaceutical, nutraceutical and cell based products.
 
“This facility will give our scientists and researchers the laboratory resources they need to rapidly develop new products. We’re looking forward to streamlining our development and manufacturing processes, and having the ability to test efficacy of these compounds in-house,” said Andrew Van Vurst, chief operating officer of BioStem Technologies.